936 results on '"Kelsen David"'
Search Results
2. Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer
3. Mapping the tumor stress network reveals dynamic shifts in the stromal oxidative stress response
4. Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers
5. Colitis-Associated Cancers
6. Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review.
7. Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer.
8. Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma
9. BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling
10. Attitudes toward preimplantation genetic testing and quality of life among individuals with hereditary diffuse gastric cancer syndrome
11. Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients
12. Cell-free DNA (cfDNA) and Exosome Profiling from a Year-Long Human Spaceflight Reveals Circulating Biomarkers
13. Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis
14. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
15. First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial
16. Assessment of the Feasibility of Hyperpolarized [1‐13C]pyruvate Whole‐Abdomen MRI using D2O Solvation in Humans
17. Assessment of the Feasibility of Hyperpolarized [1‐13C]pyruvate Whole‐Abdomen MRI using D2O Solvation in Humans.
18. Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials
19. Positron-Emission Tomography Scan–Directed Chemoradiation for Esophageal Squamous Cell Carcinoma: No Benefit for a Change in Chemotherapy in Positron-Emission Tomography Nonresponders
20. Clinical characteristics and outcomes of patients with metastatic colitis-associated cancer treated with EGFR inhibitors.
21. Abstract B042: Clinical and molecular characterization of Lynch syndrome-associated pancreas adenocarcinoma (PDAC)
22. Abstract C074: Clinico-genomic characterization of N=2,460 pancreatic adenocarcinoma identifies KRASMUT dosage as prognostic of overall survival across disease stages
23. Comprehensive molecular characterization of gastric adenocarcinoma
24. Optimization of ultracentrifugation‐based method to enhance the purity and proteomic profiling depth of plasma‐derived extracellular vesicles and particles.
25. Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control Study
26. Pilot study of rapid MR pancreas screening for patients with BRCA mutation
27. Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
28. Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma
29. Mapping the tumor stress network reveals dynamic shifts in the stromal oxidative stress response
30. Heat Shock Factor 1-dependent extracellular matrix remodeling mediates the transition from chronic intestinal inflammation to colon cancer
31. Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control Study (Preprint)
32. Perioperative versus total neoadjuvant chemotherapy in gastric cancer
33. Tumour extracellular vesicles and particles induce liver metabolic dysfunction
34. Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease
35. Tumour extracellular vesicles and particles induce liver metabolic dysfunction
36. Data from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
37. Supplementary Figure Legends from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
38. Figure S1 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
39. Supplementary Figure Legends from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
40. Figure S2 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
41. Data from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
42. Supplementary Tables S1-S10 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
43. Data from Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice
44. Supplementary Figure from Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice
45. Supplementary Data from Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice
46. Data from Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer
47. Supplementary Data from A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors
48. Supplementary Data from Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer
49. Supplementary Figure Legends from Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection
50. Supplementary Data from Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.